Setting an agenda for comparative effectiveness systematic reviews in CKD care
- PMID: 22853705
- PMCID: PMC3472164
- DOI: 10.1186/1471-2369-13-74
Setting an agenda for comparative effectiveness systematic reviews in CKD care
Abstract
Systematic reviews comparing the effectiveness of strategies to prevent, detect, and treat chronic kidney disease are needed to inform patient care. We engaged stakeholders in the chronic kidney disease community to prioritize topics for future comparative effectiveness research systematic reviews. We developed a preliminary list of suggested topics and stakeholders refined and ranked topics based on their importance. Among 46 topics identified, stakeholders nominated 18 as 'high' priority. Most pertained to strategies to slow disease progression, including: (a) treat proteinuria, (b) improve access to care, (c) treat hypertension, (d) use health information technology, and (e) implement dietary strategies. Most (15 of 18) topics had been previously studied with two or more randomized controlled trials, indicating feasibility of rigorous systematic reviews. Chronic kidney disease topics rated by stakeholders as 'high priority' are varied in scope and may lead to quality systematic reviews impacting practice and policy.
Figures
Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Priorities for comparative effectiveness reviews in cardiovascular disease.Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):139-47. doi: 10.1161/CIRCOUTCOMES.111.000046. Epub 2013 Mar 12. Circ Cardiovasc Qual Outcomes. 2013. PMID: 23481525
-
The refinement of topics for systematic reviews: lessons and recommendations from the Effective Health Care Program.J Clin Epidemiol. 2014 Apr;67(4):425-32. doi: 10.1016/j.jclinepi.2013.10.023. J Clin Epidemiol. 2014. PMID: 24581296
-
Effectiveness, cost effectiveness, acceptability and implementation barriers/enablers of chronic kidney disease management programs for Indigenous people in Australia, New Zealand and Canada: a systematic review of mixed evidence.BMC Health Serv Res. 2016 Apr 6;16:119. doi: 10.1186/s12913-016-1363-0. BMC Health Serv Res. 2016. PMID: 27048280 Free PMC article. Review.
-
Palliative Care Disincentives in CKD: Changing Policy to Improve CKD Care.Am J Kidney Dis. 2018 Jun;71(6):866-873. doi: 10.1053/j.ajkd.2017.12.017. Epub 2018 Mar 3. Am J Kidney Dis. 2018. PMID: 29510920 Free PMC article. Review.
Cited by
-
Geographic variation in access among adults with kidney disease: evidence from medical expenditure panel survey, 2002-2011.BMC Health Serv Res. 2016 Oct 18;16(1):585. doi: 10.1186/s12913-016-1844-1. BMC Health Serv Res. 2016. PMID: 27756393 Free PMC article.
-
Pragmatic Clinical Trials in CKD: Opportunities and Challenges.J Am Soc Nephrol. 2016 Oct;27(10):2948-2954. doi: 10.1681/ASN.2015111264. Epub 2016 Jun 9. J Am Soc Nephrol. 2016. PMID: 27283497 Free PMC article. Review.
-
Older adults with CKD and acute kidney failure: do we know enough for critical shared decision making?J Am Soc Nephrol. 2014 Jan;25(1):5-8. doi: 10.1681/ASN.2013090981. Epub 2013 Nov 21. J Am Soc Nephrol. 2014. PMID: 24262792 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
